APA (7th ed.) Citation

Cui, R., Su, H., Jiang, Y., Yu, X., & Liu, Y. Propensity score analysis of high-dose rate brachytherapy, immune checkpoint inhibitors, and docetaxel in second-line advanced NSCLC treatment. Nature Portfolio.

Chicago Style (17th ed.) Citation

Cui, Ran, Hong Su, Yan Jiang, Xinlin Yu, and Yu Liu. Propensity Score Analysis of High-dose Rate Brachytherapy, Immune Checkpoint Inhibitors, and Docetaxel in Second-line Advanced NSCLC Treatment. Nature Portfolio.

MLA (9th ed.) Citation

Cui, Ran, et al. Propensity Score Analysis of High-dose Rate Brachytherapy, Immune Checkpoint Inhibitors, and Docetaxel in Second-line Advanced NSCLC Treatment. Nature Portfolio.